• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人工智能在急性呼吸窘迫综合征(ARDS)治疗中的潜力

[Potential of AI for the Treatment of Acute Respiratory Distress Syndrome (ARDS)].

作者信息

Bickenbach Johannes

出版信息

Anasthesiol Intensivmed Notfallmed Schmerzther. 2024 Jan;59(1):34-44. doi: 10.1055/a-2043-8644. Epub 2024 Jan 8.

DOI:10.1055/a-2043-8644
PMID:38190824
Abstract

Acute respiratory distress syndrome (ARDS) is still associated with high mortality rates and poses a significant, vital threat to ICU patients because this syndrome is often detected too late (or not at all), and timely therapy and the fastest possible elimination of the underlying causes thus fail to materialize. Artificial Intelligence (AI) solutions can enable clinicians to make every minute in the ICU work for the patient by processing and analyzing all relevant data, thus supporting early diagnosis, adhering to clinical guidelines, and even providing a prognosis for the course of the ICU. This article shows what is already possible and where further challenges lie in this field of digital medicine.

摘要

急性呼吸窘迫综合征(ARDS)仍然与高死亡率相关,并且对重症监护病房(ICU)患者构成重大的生命威胁,因为这种综合征往往发现得太晚(或者根本未被发现),从而无法实现及时治疗以及尽快消除潜在病因。人工智能(AI)解决方案能够通过处理和分析所有相关数据,让临床医生在ICU的每一分钟都能为患者所用,从而支持早期诊断、遵循临床指南,甚至为ICU病程提供预后评估。本文展示了在数字医学这一领域已经能够做到的事情以及还存在哪些进一步的挑战。

相似文献

1
[Potential of AI for the Treatment of Acute Respiratory Distress Syndrome (ARDS)].人工智能在急性呼吸窘迫综合征(ARDS)治疗中的潜力
Anasthesiol Intensivmed Notfallmed Schmerzther. 2024 Jan;59(1):34-44. doi: 10.1055/a-2043-8644. Epub 2024 Jan 8.
2
Analytics with artificial intelligence to advance the treatment of acute respiratory distress syndrome.利用人工智能进行分析,以推进急性呼吸窘迫综合征的治疗。
J Evid Based Med. 2020 Nov;13(4):301-312. doi: 10.1111/jebm.12418. Epub 2020 Nov 13.
3
Artificial intelligence in acute respiratory distress syndrome: A systematic review.人工智能在急性呼吸窘迫综合征中的应用:系统评价。
Artif Intell Med. 2022 Sep;131:102361. doi: 10.1016/j.artmed.2022.102361. Epub 2022 Jul 19.
4
Machine Learning Tools for Acute Respiratory Distress Syndrome Detection and Prediction.机器学习工具在急性呼吸窘迫综合征检测和预测中的应用。
Crit Care Med. 2024 Nov 1;52(11):1768-1780. doi: 10.1097/CCM.0000000000006390. Epub 2024 Aug 12.
5
Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries.全球 50 个国家重症监护病房急性呼吸窘迫综合征患者的流行病学、治疗模式和死亡率。
JAMA. 2016 Feb 23;315(8):788-800. doi: 10.1001/jama.2016.0291.
6
Algorithmic surveillance of ICU patients with acute respiratory distress syndrome (ASIC): protocol for a multicentre stepped-wedge cluster randomised quality improvement strategy.急性呼吸窘迫综合征 ICU 患者的算法监测(ASIC):一项多中心阶梯式楔形集群随机质量改进策略的方案。
BMJ Open. 2021 Apr 8;11(4):e045589. doi: 10.1136/bmjopen-2020-045589.
7
Rapidly improving acute respiratory distress syndrome in COVID-19: a multi-centre observational study.COVID-19 相关的急性呼吸窘迫综合征急剧恶化:一项多中心观察性研究。
Respir Res. 2022 Apr 14;23(1):94. doi: 10.1186/s12931-022-02015-8.
8
[Quality of results of therapy of acute respiratory failure : changes over a period of two decades].[急性呼吸衰竭治疗结果的质量:二十年期间的变化]
Anaesthesist. 2013 Apr;62(4):261-70. doi: 10.1007/s00101-013-2156-z. Epub 2013 Apr 6.
9
Flow controlled ventilation in Acute Respiratory Distress Syndrome associated with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 相关急性呼吸窘迫综合征的流量控制通气:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Sep 11;21(1):781. doi: 10.1186/s13063-020-04708-1.
10
Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial.双盲、随机、对照临床试验评估同种异体间充质基质细胞治疗 COVID-19 所致急性呼吸窘迫综合征患者的疗效(COVID-AT):一项随机对照试验的研究方案的结构总结。
Trials. 2021 Jan 6;22(1):9. doi: 10.1186/s13063-020-04964-1.